| RS397515405 |
KCNT1
|
Health Risk |
Pathogenic |
Autosomal dominant nocturnal frontal lobe epilepsy 5, Developmental and epileptic encephalopathy |
| RS397515406 |
KCNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nocturnal frontal lobe epilepsy 5, Developmental and epileptic encephalopathy |
| RS397515407 |
KCNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant nocturnal frontal lobe epilepsy 5, Developmental and epileptic encephalopathy |
| RS397515408 |
CRPPA
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A |
| RS397515410 |
HARS2
|
Health Risk |
Likely pathogenic |
Perrault syndrome 2, Perrault syndrome |
| RS397515411 |
CIB2
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 48, Hearing loss |
| RS397515412 |
CIB2
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 48, Autosomal recessive nonsyndromic hearing loss 48 |
| RS397515413 |
HYDIN
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS397515414 |
HYDIN
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 5, Primary ciliary dyskinesia 5 |
| RS397515415 |
HDAC8
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 5, Inborn genetic diseases |
| RS397515416 |
HDAC8
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS397515417 |
HDAC8
|
Health Risk |
Pathogenic/Likely pathogenic |
Cornelia de Lange syndrome 5, Inborn genetic diseases |
| RS397515418 |
HDAC8
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 5, Cornelia de Lange syndrome 5 |
| RS397515419 |
PEX11B
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 14B, Peroxisome biogenesis disorder 14B |
| RS397515420 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS397515421 |
RMND1
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 11, Mitochondrial disease |
| RS397515422 |
MYBPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal congenital contracture syndrome 4, Myopathy |
| RS397515423 |
PGM1
|
Health Risk |
Pathogenic |
PGM1-congenital disorder of glycosylation, PGM1-congenital disorder of glycosylation |
| RS397515424 |
DNAAF11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 19, Primary ciliary dyskinesia 19 |
| RS397515425 |
DNAAF11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 19, Primary ciliary dyskinesia 19 |
| RS397515426 |
CHMP1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Pontocerebellar hypoplasia type 8, CHMP1A-related disorder |
| RS397515427 |
MEGF8
|
Health Risk |
Pathogenic/Likely pathogenic |
MEGF8-related Carpenter syndrome, MEGF8-related Carpenter syndrome |
| RS397515428 |
MEGF8
|
Health Risk |
Pathogenic |
MEGF8-related Carpenter syndrome, MEGF8-related Carpenter syndrome |
| RS397515430 |
LTBP4
|
Health Risk |
Pathogenic |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS397515431 |
EFTUD2
|
Health Risk |
Pathogenic |
Mandibulofacial dysostosis-microcephaly syndrome, Mandibulofacial dysostosis-microcephaly syndrome |
| RS397515432 |
GDAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease recessive intermediate A, Charcot-Marie-Tooth disease type 4A |
| RS397515433 |
PDE4D
|
Health Risk |
Pathogenic |
Acrodysostosis 2 with or without hormone resistance, Acrodysostosis 2 with or without hormone resistance |
| RS397515434 |
IRF6
|
Health Risk |
Pathogenic |
Van der Woude syndrome 1, Van der Woude syndrome |
| RS397515435 |
OTOF
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 9, Nonsyndromic genetic hearing loss |
| RS397515436 |
STIM1
|
Health Risk |
Pathogenic |
Myopathy, autophagic vacuolar |
| RS397515437 |
VCAN
|
Health Risk |
Pathogenic |
Wagner disease, Wagner disease |
| RS397515438 |
JAM3
|
Health Risk |
Pathogenic |
Porencephaly-microcephaly-bilateral congenital cataract syndrome, Porencephaly-microcephaly-bilateral congenital cataract syndrome |
| RS397515439 |
JAM3
|
Health Risk |
Pathogenic |
Porencephaly-microcephaly-bilateral congenital cataract syndrome, Porencephaly-microcephaly-bilateral congenital cataract syndrome |
| RS397515440 |
NUBPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 21 |
| RS397515441 |
GDAP1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2K, Charcot-Marie-Tooth disease type 4A |
| RS397515442 |
GDAP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2K, Charcot-Marie-Tooth disease type 4A |
| RS397515443 |
GDAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2K, Charcot-Marie-Tooth disease axonal type 2K |
| RS397515445 |
FGFR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 2 with anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS397515446 |
FGFR1
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 2 with anosmia, Hypogonadotropic hypogonadism 2 with or without anosmia |
| RS397515447 |
NDUFS1
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 5 |
| RS397515448 |
ZEB2
|
Health Risk |
Likely pathogenic |
Mowat-Wilson syndrome, Inborn genetic diseases |
| RS397515449 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS397515450 |
MUSK
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 9, Congenital myasthenic syndrome 9 |
| RS397515452 |
HPSE2
|
Health Risk |
Pathogenic |
Urofacial syndrome type 1, Urofacial syndrome type 1 |
| RS397515453 |
PIK3R1
|
Health Risk |
Pathogenic/Likely pathogenic |
SHORT syndrome, Immunodeficiency 36 with lymphoproliferation |
| RS397515454 |
PLEKHG5
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease recessive intermediate C, Neuronopathy |
| RS397515455 |
PLEKHG5
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease recessive intermediate C, Neuronopathy |
| RS397515457 |
SOX10
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 2E, without neurologic involvement |
| RS397515458 |
TRDN
|
Health Risk |
Pathogenic/Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 5, Cardiovascular phenotype |
| RS397515459 |
TRDN
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 5, Cardiovascular phenotype |
| RS397515460 |
ZMYND10
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 22, Primary ciliary dyskinesia |
| RS397515461 |
DNAAF11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 19, Primary ciliary dyskinesia 19 |
| RS397515462 |
SUCLA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria |
| RS397515463 |
ELAC2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS397515464 |
ELAC2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS397515465 |
ELAC2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 17, Prostate cancer |
| RS397515466 |
ELAC2
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS397515467 |
ADAMTS18
|
Health Risk |
Pathogenic |
Microcornea-myopic chorioretinal atrophy, Microcornea-myopic chorioretinal atrophy |
| RS397515468 |
ADAMTS18
|
Health Risk |
Pathogenic |
Microcornea-myopic chorioretinal atrophy, Microcornea-myopic chorioretinal atrophy |
| RS397515469 |
ADAMTS18
|
Health Risk |
Pathogenic |
Microcornea-myopic chorioretinal atrophy, Microcornea-myopic chorioretinal atrophy |
| RS397515470 |
ACTB
|
Health Risk |
Pathogenic |
Baraitser-Winter syndrome 1, Baraitser-Winter syndrome 1 |
| RS397515475 |
KCND3
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 19/22, Spinocerebellar ataxia type 19/22 |
| RS397515476 |
KCND3
|
Health Risk |
Pathogenic |
Spinocerebellar ataxia type 19/22, Spinocerebellar ataxia type 19/22 |
| RS397515478 |
KCND3
|
Health Risk |
Likely pathogenic |
Variant of unknown significance, Spinocerebellar ataxia type 19/22 |
| RS397515479 |
RNASEH2A
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 4, Aicardi-Goutieres syndrome 4 |
| RS397515480 |
RNASEH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Aicardi-Goutieres syndrome 4, Aicardi Goutieres syndrome |
| RS397515481 |
FGFR1
|
Health Risk |
Pathogenic |
Hartsfield-Bixler-Demyer syndrome, Hartsfield-Bixler-Demyer syndrome |
| RS397515482 |
MYH7
|
Health Risk |
Likely pathogenic |
Left ventricular noncompaction 5, Left ventricular noncompaction cardiomyopathy |
| RS397515483 |
TACR3
|
Health Risk |
Pathogenic |
Hypogonadotropic hypogonadism 11 with or without anosmia, Hypogonadotropic hypogonadism 11 with or without anosmia |
| RS397515484 |
AURKC
|
Health Risk |
Pathogenic |
Infertility associated with multi-tailed spermatozoa and excessive DNA, Infertility associated with multi-tailed spermatozoa and excessive DNA |
| RS397515485 |
HCFC1
|
Health Risk |
Pathogenic |
Methylmalonic acidemia with homocystinuria, type cblX |
| RS397515486 |
HCFC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Methylmalonic acidemia with homocystinuria, type cblX |
| RS397515487 |
HCFC1
|
Health Risk |
Pathogenic |
Methylmalonic acidemia with homocystinuria, type cblX |
| RS397515488 |
RSPH9
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 12, Primary ciliary dyskinesia 12 |
| RS397515489 |
SZT2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS397515490 |
SZT2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 18 |
| RS397515496 |
COL4A5
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked Alport syndrome, Alport syndrome |
| RS397515497 |
COL4A5
|
Health Risk |
Likely pathogenic |
— |
| RS397515498 |
CFTR
|
Health Risk |
Pathogenic |
Cystic fibrosis, Congenital bilateral aplasia of vas deferens from CFTR mutation |
| RS397515499 |
ZIC2
|
Health Risk |
Pathogenic |
Holoprosencephaly 5, Holoprosencephaly 5 |
| RS397515500 |
ZIC2
|
Health Risk |
Pathogenic |
Holoprosencephaly 5, Holoprosencephaly 5 |
| RS397515502 |
SIX3
|
Health Risk |
Pathogenic |
Holoprosencephaly 2, Holoprosencephaly 2 |
| RS397515506 |
MT-ND6
|
Health Risk |
Likely pathogenic |
Leber optic atrophy, Mitochondrial disease |
| RS397515507 |
MT-ND1
|
Health Risk |
Likely pathogenic |
Leber optic atrophy, Mitochondrial disease |
| RS397515511 |
COMP
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple epiphyseal dysplasia type 1, Multiple epiphyseal dysplasia type 1 |
| RS397515514 |
FGFR3
|
Health Risk |
Pathogenic |
Thanatophoric dysplasia type 1, 14 conditions |
| RS397515516 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, HGD-related disorder |
| RS397515517 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS397515518 |
HGD
|
Health Risk |
Pathogenic |
Alkaptonuria, Alkaptonuria |
| RS397515519 |
INS
|
Health Risk |
Likely pathogenic |
Permanent neonatal diabetes mellitus, Type 1 diabetes mellitus 2 |
| RS397515522 |
TTPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS397515524 |
TTPA
|
Health Risk |
Pathogenic |
Familial isolated deficiency of vitamin E, Familial isolated deficiency of vitamin E |
| RS397515527 |
UROS
|
Health Risk |
Likely pathogenic |
Cutaneous porphyria, Cutaneous porphyria |
| RS397515533 |
WDR35
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 2, Cranioectodermal dysplasia 2 |
| RS397515534 |
WDR35
|
Health Risk |
Pathogenic |
Cranioectodermal dysplasia 2, Cranioectodermal dysplasia 2 |
| RS397515536 |
WDR35
|
Health Risk |
Likely pathogenic |
Short-rib thoracic dysplasia 7 with or without polydactyly, Cranioectodermal dysplasia 2 |
| RS397515537 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS397515538 |
RUNX2
|
Health Risk |
Likely pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS397515539 |
CLCN7
|
Health Risk |
Pathogenic |
Autosomal dominant osteopetrosis 2, CLCN7-related disorder |
| RS397515540 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 3, Primary ciliary dyskinesia |